Key points are not available for this paper at this time.
Adding GO (3 mg/m(2)) to induction chemotherapy reduces relapse risk and improves survival with little increase in toxicity.
Share your take
Add a clinician perspective alongside expert commentary.
Burnett et al. (2012) studied this question.